This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.
5 Must-Buy Stocks Ahead of Earnings Results This Month
by Nalak Das
Second-quarter 2019 earnings results have so far come in better than expected.
salesforce (CRM) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
salesforce's (CRM) Q2 fiscal 2020 results are likely to benefit from a buoyant demand landscape for its cloud offerings. However, steep expenses and unfavorable forex volatility are key challenges.
Pure Storage (PSTG) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Pure Storage's (PSTG) robust adoption of FlashArray & FlashBlade solutions is driving growth. However, currency headwinds, and high tariffs owing to trade war between the U.S. and China remains headwind.
What's in the Offing for Keysight (KEYS) in Q3 Earnings?
by Zacks Equity Research
Keysight (KEYS) rides on robust adoption driven by high demand for 5G design and test solutions primarily from telecom vendors, and a strong pipeline for new business bookings.
Zayo (ZAYO) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Zayo's (ZAYO) fiscal fourth-quarter results are likely to benefit from a diversified blue-chip customer base that comprises the largest and most sophisticated users of bandwidth.
Synopsys (SNPS) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Synopsys' (SNPS) third-quarter fiscal 2019 results are likely to benefit from the increasing uptake of its strong product portfolio. However, Huawei ban remains a major headwind for the company.
Medtronic (MDT) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Medtronic's (MDT) successful execution of growth policies should aid earnings results in the fiscal first quarter.
Factors Setting the Tone for Cree (CREE) in Q4 Earnings
by Zacks Equity Research
Cree's (CREE) fourth-quarter fiscal 2019 results are likely to benefit from ongoing momentum in Wolfspeed business amid Huawei blacklisting and other macroeconomic headwinds.
Why Cooper Cos. (COO) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Invest in Cooper Companies Stock Now
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.
XRAY vs. COO: Which Stock Is the Better Value Option?
by Zacks Equity Research
XRAY vs. COO: Which Stock Is the Better Value Option?
MCK vs. COO: Which Stock Is the Better Value Option?
by Zacks Equity Research
MCK vs. COO: Which Stock Is the Better Value Option?
Insulet (PODD) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Women Health a Top Priority Now: 3 Stocks to Watch
by Sreyoshi Mukherjee
Women's healthcare gains global importance, investors might want to keep an eye on these stocks.
Why Is Cooper Cos. (COO) Up 17.6% Since Last Earnings Report?
by Zacks Equity Research
Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens Boots (WBA) Q3 Earnings Top Estimates, Margins Dip
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division gains traction from comparable prescription volume growth and a sturdy retail prescription market.
Boston Scientific Strong on Growth Goals and Future Launches
by Zacks Equity Research
This long-range strategy will aid Boston Scientific (BSX) to deliver a solid financial footing across its MedSurg, Rhythm and Neuro plus Cardiovascular segments.
Here's Why You Should Add Bruker (BRKR) to Your Portfolio
by Zacks Equity Research
Investor confidence in Bruker stock (BRKR) is high on substantial potential of MALDI Biotyper.
Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers
by Zacks Equity Research
Bruker (BRKR) gains from several crucial product launches and acquisitions.
Cooper Cos. (COO) Is Up 0.36% in One Week: What You Should Know
by Zacks Equity Research
Does Cooper Cos. (COO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Invest in Cooper Companies Stock Now
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.
Zacks.com featured highlights include: Cooper, GW, Tencent and Bloom
by Zacks Equity Research
Zacks.com featured highlights include: Cooper, GW, Tencent and Bloom
4 Stocks to Buy for Solid Earnings Acceleration
by Tirthankar Chakraborty
Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.
Cooper Companies (COO) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Higher revenues, solid segmental performance and expansion in margins benefit Cooper Companies' (COO) Q2 earnings.
Cooper Cos. (COO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cooper Cos. (COO) delivered earnings and revenue surprises of 6.52% and 0.16%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?